Episode 176: Advocating for Patients in the Contemporary Era

Episode 176: Advocating for Patients in the Contemporary Era

Dr. Grace Cordovano, a distinguished Board Certified Patient Advocate and the visionary founder of Enlightening Results, as well as the co-Founder of Unblock Health, delves into her personal journey, recounting her own wrongful diagnosis of advanced lymphoma and how it propelled her into the realm of patient advocacy.

Drawing from her extensive experience, she sheds light on the diverse array of individuals who seek her guidance and the multifaceted challenges they face, from navigating the complexities of tumor boards to grappling with insurance denials and prior authorizations. Dr. Cordovano also illuminates her innovative approach, harnessing the power of AI to provide patient-centric counsel and support. With a deep commitment to advocating for patients at every stage of their healthcare journey, she shares insights into her involvement in end-of-life care and offers invaluable perspectives on advocating for patients in the contemporary era.

Related Resources

N/A

Subscribe to Healthcare Unfiltered

Other Episodes You May Enjoy...

Episode 223: From Lab to Statup: Dr. Simrit Parmar on Launching Cellenkos

Dr. Simrit Parmar, founder of Cellenkos, joins the show to discuss her journey from the lab to the biotech startup world, detailing the inspiration behind launching her company, the challenges of securing funding, and the resilience required to overcome rejections. She shares insights into Cellenkos’ lead product, its progress toward market approval, and the rigorous

Read More

Episode 222: Language Matters: A Patient Perspective

Carol Rausch—a healthcare professional, cancer researcher, and former patient with lymphoma—shares how her journey from researcher to patient transformed her understanding of medical language. She discusses the impact of word choice on patients, why certain battle and war metaphors can be harmful, and how language used in clinical settings differs from what resonates with those

Read More

Episode 221: Major Progress in Adjuvant Renal Cell Carcinoma

Drs. David Braun and Toni Choueiri join to discuss a groundbreaking Nature study on a personalized neoantigen vaccine for adjuvant renal cell carcinoma. They explore the inspiration behind the trial, how the vaccine was developed and administered, and its safety profile. The conversation also covers patient outcomes after 3-4 years, including immune responses and disease

Read More